Security key
67080T108
- Security type / class
- Equity / COM
- Total 13F shares
- 4,519,840
- Total 13F value
- $34,936,893
- Share change
- +268,584
- Put/Call ratio
- 0%
- SEC-reported price per share
- $7.73
- Number of holders
- 62
- Value change
- +$2,076,848
- Number of buys
- 33
- Number of sells
- 10
Show 1 more signal
Report period
Q1 2026
Institutions
62
Top holders
10
NVCT full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
Nuvectis Pharma, Inc. SEC filings
Nuvectis Pharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 67080T108
Recent filing periods:
Ownership snapshot
Top reported holders of NVCT - Nuvectis Pharma, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ron Bentsur
Disclosed value leader
Ron Bentsur
Comparable rows
0/15
Latest evidence
06 Jan 2026
3/4/5
13F
Highest disclosed value: $27,752,858
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Ron Bentsur has the largest disclosed position value at $27.75M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Disclosed position value
Top 5
Ron Bentsur
$27.75M
Marlio Charles Mosseri
$20.36M
Enrique Poradosu
$13.64M
Shay Shemesh
$13.54M
VANGUARD GROUP INC
$6.38M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ron Bentsur |
3/4/5
Chairman & CEO, Director, 10%+ Owner
|
—
class O/S missing
|
$27,752,858
3,675,924 shares
|
+$28,600 | 06 Jan 2026 |
| Marlio Charles Mosseri |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$20,355,809
3,245,897 shares
|
+$1,271,383 | 23 Oct 2025 |
| Enrique Poradosu |
3/4/5
Chief Science & Business Off
|
—
class O/S missing
|
$13,637,527
1,806,319 shares
|
— | 06 Jan 2026 |
| Shay Shemesh |
3/4/5
Chief Dev. & Ops. Officer
|
—
class O/S missing
|
$13,537,484
1,793,068 shares
|
— | 06 Jan 2026 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$6,383,541
845,502 shares
|
— | 31 Dec 2025 |
| BlackRock, Inc. |
13F
Company
|
—
class O/S missing
|
$5,910,179
782,805 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
62
Shares
4,519,840
Rows available
62
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
47
Q1 2026 holders
62
Holder diff
15
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend